We’re excited to share that BioXconomy has published an article featuring Caszyme.
In this interview, CEO Monika Paule discusses how strategic collaborations are shaping the future of CRISPR gene editing, sharing about the journey of our partnership with Integra Therapeutics.
Learn how leveraging diverse expertise enables us to transform scientific breakthroughs into tangible, impactful solutions: https://www.bioxconomy.com/partnering/partnerships-underpin-the-crispr-revolution-says-caszyme-ceo.